The mechanisms of IDH mutations in tumorigenesis

被引:33
作者
Ye, Dan [1 ]
Xiong, Yue [1 ,2 ,4 ]
Guan, Kun-Liang [1 ,3 ,5 ,6 ]
机构
[1] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China
[2] Fudan Univ, Coll Life Sci, Shanghai 200032, Peoples R China
[3] Fudan Univ, Coll Med, Shanghai 200032, Peoples R China
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
[5] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[6] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
关键词
ONCOMETABOLITE; 2-HYDROXYGLUTARATE; DIFFERENTIATION; PHENOTYPE;
D O I
10.1038/cr.2012.51
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumor-associated mutations in the isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) genes result in the loss of normal catalytic activity, the production of alpha-ketoglutarate (alpha-KG), and gain of a new activity, the production of an oncometabolite, R-2-hydroxylglutarate (R-2-HG). New evidence supports previous findings that R-2-HG acts as an antagonist of alpha-KG to competitively inhibit the activity of multiple alpha-KG-dependent dioxygenases, including both histones and DNA demethylases involved in epigenetic control of gene expression and cell differentiation, and also reveals an intriguing new facet of R-2-HG in tumorigenesis.
引用
收藏
页码:1102 / 1104
页数:3
相关论文
共 12 条
[1]   The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases [J].
Chowdhury, Rasheduzzaman ;
Yeoh, Kar Kheng ;
Tian, Ya-Min ;
Hillringhaus, Lars ;
Bagg, Eleanor A. ;
Rose, Nathan R. ;
Leung, Ivanhoe K. H. ;
Li, Xuan S. ;
Woon, Esther C. Y. ;
Yang, Ming ;
McDonough, Michael A. ;
King, Oliver N. ;
Clifton, Ian J. ;
Klose, Robert J. ;
Claridge, Timothy D. W. ;
Ratcliffe, Peter J. ;
Schofield, Christopher J. ;
Kawamura, Akane .
EMBO REPORTS, 2011, 12 (05) :463-469
[2]   Cancer-associated IDH1 mutations produce 2-hydroxyglutarate [J].
Dang, Lenny ;
White, David W. ;
Gross, Stefan ;
Bennett, Bryson D. ;
Bittinger, Mark A. ;
Driggers, Edward M. ;
Fantin, Valeria R. ;
Jang, Hyun Gyung ;
Jin, Shengfang ;
Keenan, Marie C. ;
Marks, Kevin M. ;
Prins, Robert M. ;
Ward, Patrick S. ;
Yen, Katharine E. ;
Liau, Linda M. ;
Rabinowitz, Joshua D. ;
Cantley, Lewis C. ;
Thompson, Craig B. ;
Heiden, Matthew G. Vander ;
Su, Shinsan M. .
NATURE, 2009, 462 (7274) :739-U52
[3]   Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation [J].
Figueroa, Maria E. ;
Abdel-Wahab, Omar ;
Lu, Chao ;
Ward, Patrick S. ;
Patel, Jay ;
Shih, Alan ;
Li, Yushan ;
Bhagwat, Neha ;
Vasanthakumar, Aparna ;
Fernandez, Hugo F. ;
Tallman, Martin S. ;
Sun, Zhuoxin ;
Wolniak, Kristy ;
Peeters, Justine K. ;
Liu, Wei ;
Choe, Sung E. ;
Fantin, Valeria R. ;
Paietta, Elisabeth ;
Lowenberg, Bob ;
Licht, Jonathan D. ;
Godley, Lucy A. ;
Delwel, Ruud ;
Valk, Peter J. M. ;
Thompson, Craig B. ;
Levine, Ross L. ;
Melnick, An .
CANCER CELL, 2010, 18 (06) :553-567
[4]   Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation [J].
Koivunen, Peppi ;
Lee, Sungwoo ;
Duncan, Christopher G. ;
Lopez, Giselle ;
Lu, Gang ;
Ramkissoon, Shakti ;
Losman, Julie A. ;
Joensuu, Paivi ;
Bergmann, Ulrich ;
Gross, Stefan ;
Travins, Jeremy ;
Weiss, Samuel ;
Looper, Ryan ;
Ligon, Keith L. ;
Verhaak, Roel G. W. ;
Yan, Hai ;
Kaelin, William G., Jr. .
NATURE, 2012, 483 (7390) :485-U144
[5]   IDH mutation impairs histone demethylation and results in a block to cell differentiation [J].
Lu, Chao ;
Ward, Patrick S. ;
Kapoor, Gurpreet S. ;
Rohle, Dan ;
Turcan, Sevin ;
Abdel-Wahab, Omar ;
Edwards, Christopher R. ;
Khanin, Raya ;
Figueroa, Maria E. ;
Melnick, Ari ;
Wellen, Kathryn E. ;
O'Rourke, Donald M. ;
Berger, Shelley L. ;
Chan, Timothy A. ;
Levine, Ross L. ;
Mellinghoff, Ingo K. ;
Thompson, Craig B. .
NATURE, 2012, 483 (7390) :474-U130
[6]   Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma [J].
Noushmehr, Houtan ;
Weisenberger, Daniel J. ;
Diefes, Kristin ;
Phillips, Heidi S. ;
Pujara, Kanan ;
Berman, Benjamin P. ;
Pan, Fei ;
Pelloski, Christopher E. ;
Sulman, Erik P. ;
Bhat, Krishna P. ;
Verhaak, Roel G. W. ;
Hoadley, Katherine A. ;
Hayes, D. Neil ;
Perou, Charles M. ;
Schmidt, Heather K. ;
Ding, Li ;
Wilson, Richard K. ;
Van Den Berg, David ;
Shen, Hui ;
Bengtsson, Henrik ;
Neuvial, Pierre ;
Cope, Leslie M. ;
Buckley, Jonathan ;
Herman, James G. ;
Baylin, Stephen B. ;
Laird, Peter W. ;
Aldape, Kenneth .
CANCER CELL, 2010, 17 (05) :510-522
[7]   Alterations of metabolic genes and metabolites in cancer [J].
Oermann, Eric K. ;
Wu, Jing ;
Guan, Kun-Liang ;
Xiong, Yue .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2012, 23 (04) :370-380
[8]   Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1 [J].
Seltzer, Meghan J. ;
Bennett, Bryson D. ;
Joshi, Avadhut D. ;
Gao, Ping ;
Thomas, Ajit G. ;
Ferraris, Dana V. ;
Tsukamoto, Takashi ;
Rojas, Camilo J. ;
Slusher, Barbara S. ;
Rabinowitz, Joshua D. ;
Dang, Chi V. ;
Riggins, Gregory J. .
CANCER RESEARCH, 2010, 70 (22) :8981-8987
[9]   IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype [J].
Turcan, Sevin ;
Rohle, Daniel ;
Goenka, Anuj ;
Walsh, Logan A. ;
Fang, Fang ;
Yilmaz, Emrullah ;
Campos, Carl ;
Fabius, Armida W. M. ;
Lu, Chao ;
Ward, Patrick S. ;
Thompson, Craig B. ;
Kaufman, Andrew ;
Guryanova, Olga ;
Levine, Ross ;
Heguy, Adriana ;
Viale, Agnes ;
Morris, Luc G. T. ;
Huse, Jason T. ;
Mellinghoff, Ingo K. ;
Chan, Timothy A. .
NATURE, 2012, 483 (7390) :479-U137
[10]   Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases [J].
Xu, Wei ;
Yang, Hui ;
Liu, Ying ;
Yang, Ying ;
Wang, Ping ;
Kim, Se-Hee ;
Ito, Shinsuke ;
Yang, Chen ;
Wang, Pu ;
Xiao, Meng-Tao ;
Liu, Li-xia ;
Jiang, Wen-qing ;
Liu, Jing ;
Zhang, Jin-ye ;
Wang, Bin ;
Frye, Stephen ;
Zhang, Yi ;
Xu, Yan-hui ;
Lei, Qun-ying ;
Guan, Kun-Liang ;
Zhao, Shi-min ;
Xiong, Yue .
CANCER CELL, 2011, 19 (01) :17-30